These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 19176692)

  • 1. Francisella tularensis infection-derived monoclonal antibodies provide detection, protection, and therapy.
    Savitt AG; Mena-Taboada P; Monsalve G; Benach JL
    Clin Vaccine Immunol; 2009 Mar; 16(3):414-22. PubMed ID: 19176692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Native outer membrane proteins protect mice against pulmonary challenge with virulent type A Francisella tularensis.
    Huntley JF; Conley PG; Rasko DA; Hagman KE; Apicella MA; Norgard MV
    Infect Immun; 2008 Aug; 76(8):3664-71. PubMed ID: 18505805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific antibodies protect gamma-irradiated mice against Francisella tularensis infection.
    Kubelkova K; Krocova Z; Balonova L; Pejchal J; Stulik J; Macela A
    Microb Pathog; 2012; 53(5-6):259-68. PubMed ID: 22841607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific antibodies contribute to the host protection against strains of Francisella tularensis subspecies holarctica.
    Stenmark S; Lindgren H; Tärnvik A; Sjöstedt A
    Microb Pathog; 2003 Aug; 35(2):73-80. PubMed ID: 12901846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Passive protection of mice against lethal Francisella tularensis (live tularemia vaccine strain) infection by the sera of human recipients of the live tularemia vaccine.
    Drabick JJ; Narayanan RB; Williams JC; Leduc JW; Nacy CA
    Am J Med Sci; 1994 Aug; 308(2):83-7. PubMed ID: 8042659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Francisella tularensis outer membrane protein A (FopA) as a protective antigen for tularemia.
    Hickey AJ; Hazlett KR; Kirimanjeswara GS; Metzger DW
    Vaccine; 2011 Sep; 29(40):6941-7. PubMed ID: 21803089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy of tularemia: characterization of a monoclonal antibody reactive with Francisella tularensis.
    Narayanan RB; Drabick JJ; Williams JC; Fortier AH; Meltzer MS; Sadoff JC; Bolt CR; Nacy CA
    J Leukoc Biol; 1993 Jan; 53(1):112-6. PubMed ID: 8426087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An improved vaccine for prevention of respiratory tularemia caused by Francisella tularensis SchuS4 strain.
    Bakshi CS; Malik M; Mahawar M; Kirimanjeswara GS; Hazlett KR; Palmer LE; Furie MB; Singh R; Melendez JA; Sellati TJ; Metzger DW
    Vaccine; 2008 Sep; 26(41):5276-88. PubMed ID: 18692537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of the live attenuated Francisella tularensis vaccine (LVS) in a murine model of disease.
    Green M; Choules G; Rogers D; Titball RW
    Vaccine; 2005 Apr; 23(20):2680-6. PubMed ID: 15780452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis.
    KuoLee R; Harris G; Conlan JW; Chen W
    Vaccine; 2007 May; 25(19):3781-91. PubMed ID: 17346863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of antibody to lipopolysaccharide in protection against low- and high-virulence strains of Francisella tularensis.
    Fulop M; Mastroeni P; Green M; Titball RW
    Vaccine; 2001 Aug; 19(31):4465-72. PubMed ID: 11483272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neisseria meningitidis PorB, a Toll-like receptor 2 ligand, improves the capacity of Francisella tularensis lipopolysaccharide to protect mice against experimental tularemia.
    Chiavolini D; Weir S; Murphy JR; Wetzler LM
    Clin Vaccine Immunol; 2008 Sep; 15(9):1322-9. PubMed ID: 18614668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Francisella tularensis Live Vaccine Strain deficient in capB and overexpressing the fusion protein of IglA, IglB, and IglC from the bfr promoter induces improved protection against F. tularensis respiratory challenge.
    Jia Q; Bowen R; Lee BY; Dillon BJ; Masleša-Galić S; Horwitz MA
    Vaccine; 2016 Sep; 34(41):4969-4978. PubMed ID: 27577555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation and characterization of hybridoma antibodies for immunotherapy of tularemia.
    Lu Z; Roche MI; Hui JH; Unal B; Felgner PL; Gulati S; Madico G; Sharon J
    Immunol Lett; 2007 Oct; 112(2):92-103. PubMed ID: 17764754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant attenuated Listeria monocytogenes vaccine expressing Francisella tularensis IglC induces protection in mice against aerosolized Type A F. tularensis.
    Jia Q; Lee BY; Clemens DL; Bowen RA; Horwitz MA
    Vaccine; 2009 Feb; 27(8):1216-29. PubMed ID: 19126421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen-specific B-1a antibodies induced by Francisella tularensis LPS provide long-term protection against F. tularensis LVS challenge.
    Cole LE; Yang Y; Elkins KL; Fernandez ET; Qureshi N; Shlomchik MJ; Herzenberg LA; Herzenberg LA; Vogel SN
    Proc Natl Acad Sci U S A; 2009 Mar; 106(11):4343-8. PubMed ID: 19251656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monophosphoryl Lipid A Enhances Efficacy of a Francisella tularensis LVS-Catanionic Nanoparticle Subunit Vaccine against F. tularensis Schu S4 Challenge by Augmenting both Humoral and Cellular Immunity.
    Richard K; Mann BJ; Qin A; Barry EM; Ernst RK; Vogel SN
    Clin Vaccine Immunol; 2017 Mar; 24(3):. PubMed ID: 28077440
    [No Abstract]   [Full Text] [Related]  

  • 18. Tularemia in BALB/c and C57BL/6 mice vaccinated with Francisella tularensis LVS and challenged intradermally, or by aerosol with virulent isolates of the pathogen: protection varies depending on pathogen virulence, route of exposure, and host genetic background.
    Chen W; Shen H; Webb A; KuoLee R; Conlan JW
    Vaccine; 2003 Sep; 21(25-26):3690-700. PubMed ID: 12922099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Francisella novicida LPS has greater immunobiological activity in mice than F. tularensis LPS, and contributes to F. novicida murine pathogenesis.
    Kieffer TL; Cowley S; Nano FE; Elkins KL
    Microbes Infect; 2003 Apr; 5(5):397-403. PubMed ID: 12737995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purified lipopolysaccharide from Francisella tularensis live vaccine strain (LVS) induces protective immunity against LVS infection that requires B cells and gamma interferon.
    Dreisbach VC; Cowley S; Elkins KL
    Infect Immun; 2000 Apr; 68(4):1988-96. PubMed ID: 10722593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.